{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:39:49Z","timestamp":1782837589835,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.vaccine.2020.07.043","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T02:20:48Z","timestamp":1596162048000},"page":"6280-6290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets"],"prefix":"10.1016","volume":"38","author":[{"given":"Leena R.","family":"Yeolekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Guilfoyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parikshit","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert J.","family":"Stittelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"van Amerongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev M.","family":"Dhere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"BerlandaScorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kutub","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.07.043_b0005","unstructured":"Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting. Bull World Health Organ 1995; 73(4): 431\u201335."},{"key":"10.1016\/j.vaccine.2020.07.043_b0010","doi-asserted-by":"crossref","first-page":"P-104","DOI":"10.1186\/1753-6561-5-S8-P104","article-title":"Development of live cultural pandemic influenza vaccine Vector-Flu","volume":"5 Suppl 8","author":"Nechaeva","year":"2011","journal-title":"BMC Proc"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.043_b0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1750-2659.2011.00291.x","article-title":"Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and liveH5 vaccine)","volume":"6","author":"Gambaryan","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2020.07.043_b0020","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1016\/j.vaccine.2010.03.005","article-title":"Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells","volume":"28","author":"Hussain","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2020.07.043_b0025","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1128\/jcm.35.7.1900-1901.1997","article-title":"Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human lung embryonated cells (MRC-5) in the isolation of influenza A virus from nasopharyngeal aspirates by shell vial culture","volume":"35","author":"Reina","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"13","key":"10.1016\/j.vaccine.2020.07.043_b0030","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0264-410X(98)00011-5","article-title":"Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture","volume":"16","author":"Halperin","year":"1998","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.07.043_b0035","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/j.vaccine.2011.04.119","article-title":"A pandemic influenza vaccine in India: from strain to sale within 12 months","volume":"29","author":"Dhere","year":"2011","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2020.07.043_b0040","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1016\/j.vaccine.2018.10.002","article-title":"Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains","volume":"36","author":"Yeolekar","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2020.07.043_b0045","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/CVI.05116-11","article-title":"Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine","volume":"18","author":"Chirkova","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.07.043_b0050","first-page":"29","article-title":"Genome Composition Analysis of the Reassortant Influenza Viruses Used in Seasonal and Pandemic Live Attenuated Influenza Vaccine","volume":"4","author":"Kiseleva","year":"2011","journal-title":"Mol Gen Mikrobiol Virusol"},{"key":"10.1016\/j.vaccine.2020.07.043_b0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.virol.2015.03.017","article-title":"Ferret models of viral pathogenesis","volume":"479\u2013480","author":"Enkirch","year":"2015","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.043_b0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2011.01.004","article-title":"Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A\/Leningrad\/134\/17\/57 (H2N2)","volume":"412","author":"Isakova-Sivak","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.07.043_b0065","unstructured":"WHO. Technical Report Series No. 977. Annex 4. Recommendations to assure the quality, safety and efficacy of influenza vaccines (human, live attenuated) for intranasal administration. 2013; P153. Available at: https:\/\/www.who.int\/biologicals\/areas\/vaccines\/influenza\/TRS_977_Annex_4.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2020.07.043_b0070","unstructured":"WHO global influenza surveillance network. Manual for the laboratory diagnosis and virological surveillance of influenza. Part 2.F. Serological diagnosis of influenza by haemagglutination inhibition testing. 2011; P59-62. Available at : https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44518\/9789241548090_eng.pdf."},{"key":"10.1016\/j.vaccine.2020.07.043_b0075","unstructured":"WHO global influenza surveillance network. Manual for the laboratory diagnosis and virological surveillance of influenza. Part 2.G. Serological diagnosis of influenza by microneutralization assay. 2011; P63-78. Available at : https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44518\/9789241548090_eng.pdf."},{"issue":"7","key":"10.1016\/j.vaccine.2020.07.043_b0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/es60130a004","article-title":"Trimmed spearman-karber method for estimating median lethal concentrations in toxicity bioassays","volume":"11","author":"Martin","year":"1977","journal-title":"Environ Sci Technol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.043_b0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/14760584.2015.979159","article-title":"Pandemic preparedness with live attenuated influenza vaccines based onA\/Leningrad\/134\/17\/57 master donor virus","volume":"14","author":"Rudenko","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"45","key":"10.1016\/j.vaccine.2020.07.043_b0090","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1016\/j.vaccine.2016.08.018","article-title":"Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories","volume":"34","author":"Rudenko","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.043_b0095","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1086\/650171","article-title":"Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production","volume":"50","author":"Plotkin","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2020.07.043_b0100","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/infdis\/jir596","article-title":"Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets","volume":"204","author":"Gustin","year":"2011","journal-title":"J Infect Dis"},{"issue":"39","key":"10.1016\/j.vaccine.2020.07.043_b0105","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1016\/j.vaccine.2014.05.030","article-title":"Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers","volume":"32","author":"Heldens","year":"2014","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2020.07.043_b0110","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.vaccine.2009.02.035","article-title":"Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine(LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method","volume":"27","author":"Petukhova","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.043_b0115","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/CVI.00819-13","article-title":"Characterization of reverse genetics-derived cold-adapted master donor virus A\/Leningrad\/134\/17\/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model","volume":"21","author":"Isakova-Sivak","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.043_b0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.vaccine.2014.11.008","article-title":"Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine","volume":"33","author":"Carter","year":"2015","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2020.07.043_b0125","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.1016\/j.vaccine.2015.09.050","article-title":"Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses","volume":"33","author":"Kiseleva","year":"2015","journal-title":"Vaccine"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2020.07.043_b0130","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/S0264-410X(03)00214-7","article-title":"Non-responders to egg grown influenza vaccine seroconvert after booster immunization with MDCK cell grown vaccine","volume":"21","author":"Oxford","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20309725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20309725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:11Z","timestamp":1759402031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20309725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":26,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0264410X20309725"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}